Keywords: scottish, medicines, consortium, clears, use, roche, pegasys

Scottish Medicines Consortium clears use of Roche's Pegasys for HBV

Article | 18 July 2005

Print This

The Scottish Medicines Consortium has approved Roche's Pegasys (peginterferon alfa-2a) for the treatment of chronic hepatitis B. The agent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in